Chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) are two of the most widespread lymphoproliferative disorders among the adult population of Ukraine and other Central and Western European countries. Considering that pharmaceutical treatment accounts for the major part of medical expenses in the management of these conditions, the aim of this study was to assess the costs of pharmacotherapy of CLL and MM. The analysis was performed retrospectively using the results of our own pilot study, in which we examined medical histories of the patients treated at a specialized medical center in Kiev. The average annual cost of pharmacotherapy of all Ukrainian patients was 340 750 162 RUB for CLL and 89 184 759 RUB for MM. We found a negative correlation between the patient’s age and the cost of pharmacotherapy.

Additional Metadata
Keywords cost of treatment, lymphoproliferative disorders
Persistent URL hdl.handle.net/1765/40644
Journal Medicinskie tehnologii. Ocenka i vybo - Медицинские технологии. Оценка и выбор
Citation
Mandrik, E.A, Zalis'ka, O, & Severens, J.L. (2012). Costs of Treating Lymphoproliferative Disorders in Ukraine: a Pilot Evaluation. Medicinskie tehnologii. Ocenka i vybo - Медицинские технологии. Оценка и выбор , 2012(Special issue), 73–76. Retrieved from http://hdl.handle.net/1765/40644